T cell subset profile in healthy Zambian adults at the University Teaching Hospital

T cell subset profile in healthy Zambian adults at the University Teaching Hospital

Caroline Cleopatra Chisenga^1,&, Paul Kelly^1,2

 

¹Tropical Gastroenterology and Nutrition Group, University of Zambia School of Medicine, Lusaka, Zambia, ²Blizard Institute Barts and The London School of Medicine, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK and TROPGAN Group Department of Internal Medicine University of Zambia School of Medicine Nationalist Road, Lusaka, Zambia

 

 

^&Corresponding author
Caroline Cleopatra Chisenga, TROPGAN, Department of Medicine, University of Zambia School of Medicine, Nationalist Road, Lusaka, Zambia

 

 

 

 

Many AIDS-related research studies are being conducted in Zambia and other African nations with a high prevalence of HIV infection. Common to these studies, is the measurements of total CD4 cell count, CD4 percentage and CD4/CD8 ratio in the peripheral blood. The enumeration of circulating CD4 and CD8 lymphocyte subsets is important because these cells are perturbed during HIV infection. Additionally, CD4 and CD8 measurements have been found to be useful surrogates for determining the risk of progression of HIV infection and are widely used in observational studies and AIDS clinical trials [1]. In low-income settings, HIV/AIDS related deaths are higher than in high-income settings [2]. One of the causes for this increased dearly mortality is having very low CD4 count at the start of antiretroviral therapy (ART) [3]. Studies conducted in Zambia have revealed that T cell subsets may be an accurate predictor of early mortality in HIV-infected adults [4] as well as in children [5] starting ART. However, there are no comparative data especially on normal parameters for T cell subsets in healthy adults. Several studies have evaluated CD4 and CD8 lymphocyte subsets in children [6-9] and adults in Western nations [10-15] and other countries [16-19]. However, data on normal ranges of CD4 and CD8 T cell subsets in Zambia are generally lacking. Thus, because of the lack of normal reference ranges for CD4 and CD8 T cell subset parameters in healthy African subjects, many investigators interpret their data using values that have been derived from populations in Europe and the United States. It would therefore be helpful to establish appropriate normal reference values for T cell subsets especially in African populations. In this study, we describe CD4 and CD8T cell subset reference ranges obtained by studying 51 symptom-free HIV-seronegative Zambians.

 

 

Study participants and area: participants were identified amongst staff of the University Teaching Hospital (UTH) between February and March 2015. Participants gave written informed consent. A total of 52 healthy volunteers consented and were recruited. Of the 52 participants; 20 were laboratory scientists, 22 medical students, 4 data clerks in the out-patient department, 1 nurse and the rest in administration (accountants).

 

Ethical approval: the University of Zambia Biomedical Research Ethics Committee approved the study (Ref. No. 009-01-11).

 

Participant selection: inclusion criteria were at least 18 to 65 yrs old (either male or female), in good health, with normal full blood count parameters and of normal nutritional status. Exclusion criteria were HIV seropositive, HBsAg seropositive, hepatitis C virus seropositive, syphilis seropositive, participating in another conflicting study, pregnancy or having any chronic disease. All donors were evaluated for height, weight and grip strength using a grip strength dynamometer (Takei, Japan city)

 

Qualitative testing HIV-1/HIV-2, HCV and HBsAg: following consent, 10 mls blood were collected into three EDTA tubes for haematology testing in the UTH haematology laboratory, CD4 and CD8 testing in the UTH virology laboratory and for HIV, syphilis, HBsAg and anti-HCV testing by ELISA. All the blood samples were delivered to the laboratory within 1 hour of collection. The ARCHITECT System Abbott i2000 (Abbott, Germany) was used to qualitatively detect HIV p24 antigen and antibodies to HIV-1/HIV-2, antibodies to anti-HCV, HBsAg and syphilis in plasma. The ARCHITECT qualitative assay is a chemiluminescent microparticle immunoassay (CMIA) for the qualitative detection of antibodies/antigens in serum or plasma. The presence or absence of antibodies or antigens in the sample was determined by comparing the chemiluminescent signal in the reaction to the cut-off signal, which was determined from an active calibration. Samples with a chemiluminescent signal greater than or equal to the cut-off signal were considered as reactive.

 

Haematological analysis: haemoglobin measurements were undertaken immediately on whole blood on a Sysmex xt 4000i automated haematology analyser (Sysmex Corporation, Kobe, Japan).

 

Total CD4 and CD8 estimation: to measure total CD4 and CD8 counts, we used a FACSCaliber flow cytometer (Becton Dickinson, San Jose, USA) with MultiSET V2.2 software. CD3/CD4/CD45 TruC v2.0 (BD Biosciences) were used, and 15000 events were acquired. Antibodies used were conjugated to the following fluorochromes as follows: CD45-PerCP CD4-PE CD3-FITC.

 

CD4⁺ and CD8⁺ T cell subset testing (immunophenotyping): to measure subsets, 100 μL of whole blood was stained for a wide range of markers: CD3, CD4, CD8, α4β7 integrin(gut homing panel), Ki67 (Proliferating panel), CCR7 and CD54RA (differentiation panel), CD57 (senescent panel), CD28, CD27 and HLA-DRor CD25 (activation panel). Cells were fixed, washed, and resuspended in 250 μL par formaldehyde or 250 μL BD Cell Fix diluted according the manufacturer's (BD Biosciences) instructions and 50-100,000 lymphocytes acquired on a FACS verse flow cytometer (Becton Dickinson, San Jose, USA). Intracellular Ki-67 staining was carried out following nuclear membrane permeabilisation (BD Perm/Wash ^TM buffer from Becton Dickinson, San Jose, and U.S.A). Unstained cells and fluorescence minus one (FMO) controls were used to set all gates. Analysis of markers was carried out using BD FACSuite ^TM software v1.0.2.

 

Data analysis: data were entered and analysed using STATA software version 13 (StataCorp LP, College Station, Texas, USA). T cell markers were determined to be non-parametrically distributed using Shapiro-Wilk W test for normality, so data are presented as medians and inter quartile ranges and variables compared using the Mann-Witney U test. The χ² test was used for testing associations of categorical variables. P values less than 0.05 were considered statistically significant. Reference intervals were derived from 2.5^th and 97.5^th centiles for that variable.

 

 

Characteristics of study participants

 

There were more men than women among the staff members recruited to this study, and the majority of these were in formal employment with a median age of 29 (IQR, 25-37) years (Table 1). Haemoglobin, body mass index (BMI) and grip strength results for both male and female participants were within international normal ranges. As expected, grip strength differed substantially by sex. Median total CD4 count was 824 (IQR, 558-1044) cells/μL and median CD8 count was 1371 (IQR, 1136-771) cells/μL. Most of the individuals were married and had attained university education.

 

CD4⁺and CD8⁺T cell subset distribution in healthy adult volunteers

 

Non-viable (CD4⁺7AAD⁺) CD4+ T cells were completely absent in the healthy participants (data not shown). Figure 1 shows that majority of the CD4+ T cells in healthy adults were naïve (CCR7⁺CD45RA⁺) cells (median 753; IQR, 418-885 cells/μL), followed by recent thymic emigrant (CD31+CD45RA+) cells (median 30; IQR 22-35), gut homing cells (α4⁺β7⁺) 271 (IQR, 198-408) and gut homing and activated (α4⁺β7⁺CD25⁺) CD4⁺ T cells 170 (IQR, 129-269). In the CD8⁺ T cell subsets (Figure 2), there were no homing activated cells. Generally, cells expressing activation markers were minimal (2; 0-6), as were cells expressing proliferation markers (28;17-38), non-viable cells (zero) and cells expressing both proliferation and activation markers (10; 4-19). CD8+cells included recent thymic emigrants (149, 105-381), central memory (191, 109-282), senescent 2 (CD57⁺CD28^-) cells (164, 36-332) and naïve CD8⁺ T cells (255, 127-401).Thus, in the CD8⁺ T cells population, the majority of cells are gut homing cells (617, 429-985) followed by effect or cells (564, 305-732).

 

CD4 and CD8 subset reference intervals in healthy adults differ by sex: stratification by sex showed that females had higher total CD4⁺ count (p=0.003), activated gut homing (p=0.01), naïve (p=0.02), effect or memory (p=0.01) and effect or (p=0.01) CD4⁺ T cells than males (Table 2). Where as in the CD8⁺ population, only effect or cells were significantly different (p=0.03) between the females and males (Table 2). However, although females had higher CD4 and CD8 cells than the males, the overall distribution of both CD4 and CD8 was similar.

 

 

In order to generate a reference group, a six colour FACSVerse instrument was used to characterise the CD4⁺ and CD8⁺ T cells in HIV-negative adults in a Zambian population. Overall, we found more CD8 cells than CD4 cells (ratio of 1.67) in our Zambian population, contrary to what has been reported in other African studies and in Europe [20,21]. With men and women taken together, the mean (SD) CD4⁺ cell count was 828 (336) cells/μL, which is higher than the values reported for healthy adult Ethiopians [22]. The values were comparable to those in Tanzanians [23] and lower than those reported for Ugandans [24].

 

Our data show that in healthy adults the majority of the CD4⁺ T cells were naïve. This finding was similar to findings from a study conducted in a similar cohort in San Francisco USA [25]. However, results for the healthy Ethiopians and Dutch showed lower numbers of naïve CD4⁺ T cells [26] compared to what was found in the Zambian cohort. When naïve CD4⁺ T cells are stimulated by their cognate antigen presented by competent antigen-presenting cells they differentiate into specialized effect or and/or memory cells. Effect or T cells induce cytolysis of infected cells or activate other lymphocytes and immune effect or cells, whereas memory T cells maintain the capacity to respond rapidly to previously encountered antigens [27]. In the healthy volunteers, however, there were very few circulating effector and or memory CD4⁺ T cells in the blood compared to effector and effector memory CD8⁺ T cells. Proliferating, proliferating and activated, activated and senescent CD4⁺ T cells in the healthy volunteers were very few. Since activation is triggered by the presence of antigen and is followed by proliferation, having few proliferating and activated cells may indicate absence of infectious disease and good T cell activation regulation in our healthy volunteers [28]. Furthermore, during infection, persistent T cell activation drives proliferation that results in the accumulation of senescent, antigen-experienced memory T cells with reduced expression of CD28 and increased expression of CD57 [29]. We found a higher number of senescent CD8⁺ T cells in the HIV-negative cohorts. Expression of CD 57 has been linked to greater resistance to apoptosis in CD8⁺ T lymphocytes especially during HIV-infection, facilitating accumulation [30]. Since CD8⁺ T cells are crucial to the recognition and clearance of virus-infected cells [31] a high number of senescent CD8⁺ T cells may compromise the ability of T cell immunity to suppress viral infections adequately. We also found a high number of CD4⁺ T cells expressing gut homing markers (about 35%) and activated gut homing (23%) in these healthy adults. In the CD8+population, approximately 39% were expressing gut homing cells. Gut homing cells are cells that are programmed to migrate to gut associated lymphoid tissues especially when there is an infectious challenge to the gut [32]. Finally, there were significant differences in absolute CD4 count between females and males in some of the subsets. The reference range of CD4 count was significantly higher in females than in the males, which is in agreement with other studies in Africa [33, 21]. We do not know whether this difference is due to environmental or genetic factors.

 

Our study has several limitations. All subjects were bled only once; therefore, it is possible that some subjects were in the "window" period of HIV infection, having been recently infected with HIV but not yet having developed anti-HIV antibodies. We did not perform medical or other laboratory examinations to evaluate the subjects´ general state of health but relied on self-reported symptom histories which may be inaccurate in excluding disease in individuals presenting for voluntary HIV screening. Therefore, the parameters used to describe the healthy volunteers were not exhaustive and as such, there could be other chronic viral infections such as cytomegalovirus or Epstein-Barr virus, which could have affected the CD4 and CD8 results. CD4 counts have been found to have significant diurnal and day-to-day variation in the same subjects and to vary with storage time and temperature [34]. While all blood samples were obtained during the late morning, stored at room temperature, and processed within a maximum of 2h after phlebotomy to minimize variability due to time of day and storage time and temperature among different subjects, we performed only single determinations of absolute CD4 count, and absolute CD8 count for each subject and cannot, therefore, comment on variability due to day-to-day variation among individuals. Furthermore, the sample size was small and samples were drawn from the same area.

 

 

We propose that these reference intervals may be a useful point of comparison for studies on the immune system in Africa.

 

 

Authors declare no competing interests.

 

 

The originator of the study was Caroline C. Chisenga. Both Caroline and Paul Kelly contributed through writing, data analysis and collection. All authors have read and approved the final version of the manuscript.

 

 

We would like to thank Kanekwa Betty Zyambo for her excellent technical support.

 

 

Table 1: baseline characteristics for the participants

Table 2: CD4 and CD8 subset reference intervals in healthy population stratified by sex

Figure 1: total CD4 and subset distribution in healthy Zambian adults using surface marker expression

Figure 2: shows total CD8 and subset distribution in healthy adults using surface marker expression

 

 

1. Stein Daniel, Korvick Joyce,Vermund Sten. CD41 lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis. 1992; 165 (2):352-363. PubMed | Google Scholar


2. Braitstein P, Brinkhof M W, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg DR, Balestre E, Sterne JA, May M, Egger M. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lan. 2006; 367(9513): 817-824. PubMed | Google Scholar


3. Wamalwa Dalton C, Obimbo Elizabeth M, Farquhar Carey, Richardson Barbra A, Mbori-Ngacha Dorothy A, Inwani Irene, Benki-Nugent Sara, John-Stewart Grace. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010; 10(33): 1471-2431. PubMed | Google Scholar


4. Chisenga Caroline C, Filteau Suzanne, Siame Joshua, Chisenga, Molly, Prendergast Andrew J, Kelly Paul. T-Cell subsets predict mortality in malnourished Zambian adults initiating antiretroviral therapy. PLoS ONE. 2015; 10(6): e0129928. PubMed | Google Scholar


5. Rainwater-Lovett Kaitlin, Nkamba Hope C, Mbewe Mwangelwa M, Moore, Carolyn B, Moss William J. Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children. AIDS Res Hum Retro. 2012; 29(3): 479-487. PubMed | Google Scholar


6. Lee BW, Yap HK, Chew FT, Quah TC, Prabhakaran K, Chan GS, Wong SC , Seah CC. Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood. Cytometry. 1996;26 (1):8-15. PubMed | Google Scholar


7. Heldrup J, Kalm O, Prellner K. Blood T and B lymphocyte subpopulations in healthy infants and children. Acta Paediatr. 1992; 81(2):125-132. PubMed | Google Scholar


8. Robinson M, O'Donohoe J, Dadian G, Wankowicz A, Barltrop D, Hobbs JR. An analysis of the normal ranges of lymphocyte subpopulations in children aged 5-13 years. Eur J Pediatr. 1996;155 (7):535-539. PubMed | Google Scholar


9. Yanase Y, Tango T, Okumura K, Tada T, Kawasaki T. Lymphocyte subsets identified by monoclonal antibodies in healthy children. Pediatr Res. 1986;20 (5):1147-1151. PubMed | Google Scholar


10. Goff LK, Habeshaw JA, Rose ML, Gracie JA, Gregory W. Normal values for the different classes of venous blood mononuclear cells defined by monoclonal antibodies. J Clin Pathol. 1985;38 (52B):54-59. PubMed | Google Scholar


11. Howard RR, Fasano CS, Frey L, Miller C H. Reference intervals of CD3, CD4, CD8, CD4/CD8, and absolute CD4 values in Asian and Non-Asian populations. Cytometry. 1996;26 (3):231-232. PubMed | Google Scholar


12. McNerlan SE, Alexander HD, Rea IM. Age-related reference intervals for lymphocyte subsets in whole blood of healthy individuals. Scand J Clin Lab Invest. 1999;59 (2):89-92. PubMed | Google Scholar


13. Ricalton NS, Roberton C, Norris JM, Rewers M, Hamman RF, Kotzin BL. Prevalence of CD8 T-cell expansions in relation to age in healthy individuals. J Gerontol A Biol Sci Med Sci. 1998;53 (3):B196-B203. PubMed | Google Scholar


14. Schaberg T, Theilacker C, Nitschke OT, Lode H. Lymphocyte subsets in peripheral blood and smoking habits. Lung. 1997;175 (6):387-394. PubMed | Google Scholar


15. Vithayasai V, Sirisanthana T, Sakonwasun C, Suvanpiyasiri C. Flow cytometric analysis of T-lymphocytes subsets in adult Thais. Asian Pac J Allergy Immunol. 1997;15 (3):141-146. PubMed | Google Scholar


16. Choong ML, Ton SH, Cheong SK. Influence of race, age and sex on the lymphocyte subsets in peripheral blood of healthy Malaysian adults. Ann Clin Biochem. 1995;32 (6):532-539. PubMed | Google Scholar


17. Dhaliwal JS, Balasubramaniam T, Quek CK, Gill HK, Nasuruddin BA. Reference ranges for lymphocyte subsets in a defined Malaysian population. Singapore Med J. 1995;36 (3):288-291. PubMed | Google Scholar


18. Shahabuddin S, al Ayed IH, el Rad MO, Qureshi MI. Lymphocyte subset reference ranges in healthy Saudi Arabian children. Pediatr Allergy Immunol. 1998;9 (1):44-48. PubMed | Google Scholar


19. Witt CS, Alpers MP. Lymphocyte subsets in Eastern Highlanders of Papua New Guinea. Papua N Guin Med J. 1991;34 (2):98-103. PubMed | Google Scholar


20. Mair C, Hawes SE, Agne HD, Sow PS, N'doye I, Manhart LE, Fu PL, Gottlieb GS, Kiviat NB. Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals. Clin Exp Immunol. 2008; 151 (3): 432-440. PubMed | Google Scholar


21. Bosire Erick M, Nyamache Anthony K, Gicheru Michael M, Khamadi Samoel A, Lihana RaphaeW, Okoth Vincent. Population specific reference ranges of CD3, CD4 and CD8 lymphocyte subsets among healthy Kenyans. AIDS Research and Therapy. 2013;10 (1):24. PubMed | Google Scholar


22. Tsegaye Aster, Messele Tsehaynesh, Tilahun Tesfaye, Hailu Ermias, Sahlu Tefera, Doorly Ronan, Fontanet Arnaud L, Rinke de Wit Tobias F. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol. 1999; 6(3): 410-4. PubMed | Google Scholar


23. Urassa W, Bakari M, Sandstrom E, Swai A, Pallangyo K, Mbena E, Mhalu F, Biberfeld G. Rate of decline of absolute number and percentage of CD4 lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania. AIDS. 2004; 18 (3): 433-8. PubMed | Google Scholar


24. Tugume Stefano B, Piwowar Estelle M, Lutalo Tom, Mugyenyi Peter N, Grant Robert M, Mangeni Fred W, Pattishall Katherine, Katongole-Mbidde Edward. Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol. 1996; 2(2): 233-5. PubMed | Google Scholar


25. Roederer Mario, Gregson Dubs J, Anderson, Michael T, Raju Paul A, Herzenberg Leonore A. CD8 naive T cell counts decrease progressively in hiv-infected adults. J Clin Invest. 1995; 95: 2061-2066. PubMed | Google Scholar


26. Messele T, Abdulkadir M, Fontanet AL, Petros B, Hamann D, Koot M, Roos MT L, Schellekens PTA, Miedema F, Rinke De Wit TF. Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol. 1999; 115 (3): 443-450. PubMed | Google Scholar


27. Ahmed Rafi, David Gray. Immunological memory and protective immunity: understanding their relation. Sci. 1996; 272 (5258): 54-60. PubMed | Google Scholar


28. Chattopadhya Pratip K, Roedere Mario. Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease. Cyto. 2011; 77 (7): 614-622. PubMed | Google Scholar


29. Focosi Daniele, Bestagno Marco, Burrone Oscar, Petrini Mario. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol. 2010; 87 (1): 107-116. PubMed | Google Scholar


30. Petrovas Constantinos, Chaon Benjamin, Ambrozak David R, Price David A, Melenhorst Joseph J, Hill Brenna J, Geldmacher Christof, Casazza Joseph P, Chattopad hyay Pratip K, Roederer Mario, Douek Daniel C, Mueller Yvonne M, Jacobson Jaffrey M, Kulkarni Viraj, Felber Barbara K, Pavlakis George N, Katsikis Peter D, Koup Richard A. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol Methods. 2009; 183 (2): 1120-1132. PubMed | Google Scholar


31. Wang Yong-Qin, Ma Xi, Lu Lingling, Zhao Limei, Zhang Xiaoqing, Xu Qingyu, Wang Yang. Defective antiviral CD8 T-cell response and viral clearance in the absence of c-Jun N-terminal kinases. Immunolo. 2014; 142 (4): 603-613. PubMed | Google Scholar


32. Shacklett Barbara L, Yang Otto O, Hausner MaryAnn, Elliott Julie, Hultin, Lance, Price Charles, Fuerst Marie, Matud Jose, Hultin Patricia, Cox Catherine, Ibarrondo Javier, Wong Johnson T, Nixon Douglas F, Anton Peter A, Jamieson D. Beth Optimization of methods to assess human mucosal T-cell responses to HIV infection and vaccination. J Immunolo Methods. 2003; 279 (1-2):17-31. PubMed | Google Scholar


33. Oladepo DK, Idigbe O. Emmanuel, Audu Rosemary A. Establishment of CD4 lymphocyte baseline in Nigeria: Project report; 2008. Google Scholar


34. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J AIDS. 1990; 3 (2):144-151. PubMed | Google Scholar